Gh Research PLC GHRS
We take great care to ensure that the data presented and summarized in this overview for GH Research PLC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding GHRS
View all-
Bvf Inc San Francisco, CA8.83MShares$112 Million4.28% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.94MShares$88.3 Million1.59% of portfolio
-
Lynx1 Capital Management LP San Juan, PR6.44MShares$82 Million26.28% of portfolio
-
Rtw Investments, LP New York, NY5.5MShares$70 Million0.99% of portfolio
-
Cormorant Asset Management, LP Boston, MA2.01MShares$25.6 Million2.35% of portfolio
-
Deep Track Capital, LP Greenwich, CT2MShares$25.4 Million0.77% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A61.97MShares$25 Million0.04% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY925KShares$11.8 Million0.26% of portfolio
-
Jefferies Financial Group Inc. New York, NY750KShares$9.54 Million0.08% of portfolio
-
Verition Fund Management LLC Greenwich, CT671KShares$8.53 Million0.04% of portfolio
Latest Institutional Activity in GHRS
Top Purchases
Top Sells
About GHRS
GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH001, an inhalable 5-MeO-DMT product candidate that has completed two Phase 1 clinical trials and Phase 1/2 clinical trial in patients with TRD. The company also develops GH002, an injectable 5-MeO-DMT product candidate; and GH003, an intranasal 5-MeO-DMT product candidate, which are in preclinical development trials with a focus on psychiatric and neurological disorders. GH Research PLC was incorporated in 2018 and is based in Dublin, Ireland.
Insider Transactions at GHRS
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|